Dashboard Tools Market News Investing Ideas Pricing About Us
Sign Up
Log in

Human Metabolome Technologies Inc
TSE:6090

Watchlist Manager
Human Metabolome Technologies Inc Logo
Human Metabolome Technologies Inc
TSE:6090
Watchlist
Price: 736 JPY -3.79% Market Closed
Market Cap: ¥4.4B
Write Note Create Alert Ask AI

Human Metabolome Technologies Inc
Investor Relations

Human Metabolome Technologies, Inc. engages in the business of diagnostic technology and medical products. The company is headquartered in Tsuruoka-Shi, Yamagata-Ken and currently employs 69 full-time employees. The company went IPO on 2013-12-24. The firm operates in two segments. The Metabolome Analysis segment engages in the provision of analysis service that analyzes metabolomics of measurement samples and reports the results to customers. The Biomarker segment is engaged in the exploration of biomarkers, and the research and development of in vitro diagnostic drugs and diagnostic equipment.

Show more
Loading
6090
Nikkei 225
1Y 3Y 5Y 10Y 15Y 20Y
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Yasuhiro Ohata
President, CFO & Director
No Bio Available
Dr. Tomoyoshi Soga Ph.D.
Co-Founder and Member of Technical Advisory Board
No Bio Available
Kenjiro Kami
COO, Executive Officer & Director
No Bio Available
Jun Nagashima
Chief Information Officer & Executive Officer
No Bio Available
Atsushi Nagashima
Executive Officer & GM of Information System Department
No Bio Available
Naotaka Kametani
Executive Officer & Chief Alliance Officer
No Bio Available

Contacts

Address
YAMAGATA-KEN
Tsuruoka-shi
246-2, Mizukami, Kakuganji
Contacts
+81235251447.0
humanmetabolome.com
sparklesyt

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Back to Top
ALPHA SPREAD
Follow us
Join more than 318,800+ value investors using Alpha Spread
Create Free Account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2026 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.